Comparison of P-5227 and thioridazine in chronic schizophrenic patients.
D000328:Adult; D001007:Anxiety / Q000187:drug effects; D001519:Behavior / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D003990:Dibenzoxepins / Q000009:adverse effects / Q000627:therapeutic use*; D004644:Emotions / Q000187:drug effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use*
D003990:Dibenzoxepins; D013881:Thioridazine